Elisa Luqman V - 09 Mar 2026 Form 4 Insider Report for Nutex Health Inc. (NUTX)

Reporting relationship: Chief Legal Officer - SEC
Issuer ticker: NUTX
Reported as of: 09 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Mar 2026, 18:27:50 UTC
Prior SEC filing: 14 Apr 2025
Source filing: View source filing
Reporting owner signature: /s/ Elisa Luqman

Key filing fact

Elisa Luqman V filed Form 4 for Nutex Health Inc. (NUTX) on 11 Mar 2026.

Key facts

This page summarizes Elisa Luqman V's Form 4 filing for Nutex Health Inc. (NUTX).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 11 Mar 2026, 18:27.

Change

Previous filing in this sequence was filed on 14 Apr 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001486189 Primary reporting owner

Luqman Elisa V

Relationship: Chief Legal Officer - SEC
Address: 1776 YORKTOWN STREET, SUITE 700, HOUSTON
Signature: /s/ Elisa Luqman
Signature date: 11 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NUTX transaction

Common Stock

Options Exercise

Transaction value
Shares: +2,084
Change %: +195%
Price: $0.000000^*
Shares after: 3,154
Date: 10 Mar 2026
Ownership: See note (4)
Footnotes: F1, F4

NUTX transaction

Common Stock

Tax liability

Transaction value
Shares: -784
Change %: -25%
Price: $86.22^*
Shares after: 2,370
Date: 10 Mar 2026
Ownership: See note (4)
Footnotes: F2, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NUTX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: +1,525
Change %: +52%
Price: $0.000000^*
Shares after: 4,441
Date: 10 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,525
Exercise price: $0.000000
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Restricted stock units convert into common stock on a one-for-one basis.

Footnote F2

Of the 2,084 shares issued subsequent to vesting, 784 shares were sold to cover tax withholding obligations.

Footnote F3

On March 11, 2026, the Reporting Person was granted 1,525 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

Footnote F4

The Reporting Person directly owns 2,360 shares. Additionally, the Reporting Person indirectly owns 10 shares through their spouse, resulting in a total beneficial ownership of 2,370 shares.